Article info

Download PDFPDF
Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner

Authors

  • Charlotte L Krieckaert Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Michael T Nurmohamed Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The NetherlandsDepartment of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Gerrit Jan Wolbink Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The NetherlandsDepartment of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Charlotte L Krieckaert, Jan van Breemen Research Institute | Reade, Reumatology, dr Jan van Breemenstraat 2, Amsterdam 1056 AB, The Netherlands; c.krieckaert{at}reade.nl
View Full Text

Citation

Krieckaert CL, Nurmohamed MT, Wolbink GJ
Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner

Publication history

  • Accepted April 14, 2012
  • First published May 14, 2012.
Online issue publication 
October 05, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.